Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2) , 103-108
- https://doi.org/10.1016/j.jns.2003.11.005
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridineMultiple Sclerosis Journal, 2001
- Evidence of an abnormal intramuscular component of fatigue in multiple sclerosisMuscle & Nerve, 1995
- l-Carnitine as a treatment of lethargy in children with chronic neurologic handicapsBrain & Development, 1994
- Effect of acetyl‐L‐carnitine on the dopaminergic system in aging brainJournal of Neuroscience Research, 1991
- Effect of aging and acetyl-l-carnitine on energetic and cholinergic metabolism in rat brain regionsMechanisms of Ageing and Development, 1989
- The social experiences of cancer patients under treatment: A comparative studySocial Science & Medicine, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- The distribution and role of carnitine in the mammalian brainLife Sciences, 1982
- Conformations of carnitine and acetylcarnitine and the relationship to mitochondrial transport of fatty acidsJournal of Theoretical Biology, 1980